Alpha 2.0
Login Register
» Authors » G B Deacon

G B Deacon

Explore the profile of G B Deacon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 126
Followers 0
Related Specialties
Chemistry
Biochemistry
Oncology
Top 10 Co-Authors
L K Webster
S Rainone
D R Phillips
P W Moors
A J Canty
T Talarico
K C Lim
B M Gatehouse
T Renouard
E Costa
Published In
J Inorg Biochem
Chemistry
J Med Chem
Met Based Drugs
J Am Chem Soc
Affiliations
Soon will be listed here.
Recent Articles
1.
A divalent heteroleptic lanthanoid fluoride complex stabilised by the tetraphenylcyclopentadienyl ligand, arising from C-F activation of pentafluorobenzene
Deacon G, Jaroschik F, Junk P, Kelly R
Chem Commun (Camb) . 2014 Aug; 50(73):10655-7. PMID: 25077602
The divalent heteroleptic lanthanoid fluoride complex, [Yb(C5Ph4H)(μ-F)(thf)2]2, as well as [Yb(C5Ph4H)2(thf)] and [Yb(C5Ph4H)(C6F5)(thf)2] were obtained from reactions of ytterbium metal with Hg(C6F5)2 and tetraphenylcyclopentadiene under different conditions, and C-F activation...
2.
Preparation and Anti-Tumour Activity of Some Arylbismuth(III) Oxine Complexes
Smith K, Deacon G, Jackson W, Tiekink E, Rainone S, Webster L
Met Based Drugs . 2008 May; 5(5):295-304. PMID: 18475861
New arylbismuth(lll) oxinates, PhBi(MeOx)(2), (p-MeC(6)H(4))Bi(Ox)(2), (p-MeC(6)H(4))Bi(MeOx)(2), (p-ClC(6)H(4))Bi(Ox)(2), and (p-ClC(6)H(4))Bi(MeOx)(2) (Ox(-) = quinolin-8-olate and MeOx(-)=2-methylquinolin-8-olate) have been prepared by reaction of the appropriate diarylbismuth chlorides with Na(Ox) or Na(MeOx) in the...
3.
Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells
Talarico T, Cullinane C, Gray P, Webster L, Deacon G, Phillips D
Anticancer Drug Des . 2002 Apr; 16(2-3):135-41. PMID: 11962511
The DNA binding pattern of the organoamidoplatinum(II) compound 1a is of considerable interest because of its known activity against cisplatin-resistant cells. The activity of 1a appears to be due at...
4.
Engineering of efficient panchromatic sensitizers for nanocrystalline TiO(2)-based solar cells
Nazeeruddin M, Pechy P, Renouard T, Zakeeruddin S, Humphry-Baker R, Comte P, et al.
J Am Chem Soc . 2001 Jul; 123(8):1613-24. PMID: 11456760
A new series of panchromatic ruthenium(II) sensitizers derived from carboxylated terpyridyl complexes of tris-thiocyanato Ru(II) have been developed. Black dye containing different degrees of protonation [(C(2)H(5))(3)NH][Ru(H(3)tcterpy)(NCS)(3)] 1, [(C(4)H(9))(4)N](2)[Ru(H(2)tcterpy)(NCS)(3)] 2, [(C(4)H(9))(4)N](3)[Ru(Htcterpy)(NCS)(3)]...
5.
Diverse heteroleptic ytterbium(III) thiocyanate complexes by oxidation from bis(thiocyanato)ytterbium(II)
Deacon G, Forsyth C, Wilkinson D
Chemistry . 2001 May; 7(8):1784-95. PMID: 11349921
The new ytterbium(II) thiocyanate complex [Yb(NCS)2(thf)2] (1), synthesised by redox transmetallation between [Hg(SCN)2] and ytterbium metal in THF at room temperature, gave monomeric, eight coordinate [Yb-(NCS)2(dme)3] (2, dme = 1,2-dimethoxyethane)...
6.
Simple syntheses, structural diversity, and Tishchenko reaction catalysis of neutral homoleptic rare earth(II or III) 3,5-di-tert-butylpyrazolates--the structures of
Deacon G, Gitlits A, Roesky P, Burgstein M, Lim K, Skelton B, et al.
Chemistry . 2001 Feb; 7(1):127-38. PMID: 11205004
The homoleptic rare-earth pyrazolate complexes [Sc(tBu2pz)3], [Ln2(tBu2pz)6] (Ln = La, Nd, Sm, Lu), [Eu4(tBu2pz)8] and the mixed oxidation state species [Yb2(tBu2pz)5] (tBu2pz = 3,5-di-tert-butylpyrazolate) have been prepared by a simple...
7.
Modifying the properties of platinum (IV) complexes in order to increase biological effectiveness
Hambley T, Battle A, Deacon G, Lawrenz E, Fallon G, Gatehouse B, et al.
J Inorg Biochem . 2000 Jan; 77(1-2):3-12. PMID: 10626347
The preparation of a series of novel Pt(IV) complexes containing the anionic polyfluoroaryl ligands, 2,3,5,6-tetrafluorophenyl (p-HC6F4), 2,3,5,6-tetrafluoro-4-methoxyphenyl (p-MeOC6F4) and pentafluorophenyl (C6F5) are described. The crystal structure of a representative complex,...
8.
Activity and DNA binding of new organoamidoplatinum (II) complexes
Talarico T, Phillips D, Deacon G, Rainone S, Webster L
Invest New Drugs . 1999 Nov; 17(1):1-15. PMID: 10555118
Two series of organoamidoplatinum (II) complexes were synthesized [Class 1, Pt(NRCH2)2L2 and Class 2, Pt(NRCH2CH2NR2')L(X)] and their antitumour activity examined by a range of in vitro, cellular and animal studies....
9.
cis-bis(pyridine)platinum(II) organoamides with unexpected growth inhibition properties and antitumor activity
Webster L, Deacon G, Buxton D, HILLCOAT B, James A, Roos I, et al.
J Med Chem . 1992 Sep; 35(18):3349-53. PMID: 1527784
The platinum(II) organoamides [Pt(NRCH2)2L2] (L = pyridine (py), R = p-HC6F4, C6F5,p-IC6F4,p-CIC6F4,p-C6F5C6F4; L = 4-methylpyridine, R = p-HC6F4) and [Pt(NRCH2CH2NR')(py)2] (R = p-HC6F4, R' = C6F5, p-BrC6F4, or p-MeC6F4) inhibit...
10.
Octanol/water partition coefficients as a model system for assessing antidotes for methylmercury(II) poisoning, and for studying mercurials with medicinal applications
Canty A, Moors P, Deacon G
J Inorg Biochem . 1984 Sep; 22(1):65-72. PMID: 6092535
1-Octanol/water partition coefficients, [HgII]octanol/[HgII]water, provide a simple but limited model system for aspects of the biological behavior of methylmercury(II) and commonly used organomercury(II) medicinal compounds. In an octanol/water system some...